Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up

Diffuse cutaneous systemic sclerosis (dcSSc) is a heterogeneous autoimmune disease characterized by progressive skin fibrosis, vasculopathy and variable organ involvement. Our recent case report about this patient described clinical improvement under IL-17A inhibition with secukinumab for worsening...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lea-Kristin Nagler, Patrick-Pascal Strunz, Hannah Labinsky, Anja Kroiß, Michael Gernert, Marc Schmalzing
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-03-01
Col·lecció:	Frontiers in Immunology
Matèries:	bimekizumab diffuse cutaneous systemic sclerosis IL17A/IL-17F interleukin-17 secukinumab systemic sclerosis
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1771650/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!